⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY
Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies
globenewswire.com
ABBV
BMY
GILD
AMGN
AZN
LLY
BIIB
REGN
VRTX
XBI
IBB
CRSP
EDIT
NTLA
ABCL
NVS
MRK
PFE
JNJ
GSK
SNY
BTAI
INSM
HFA Architecture + Engineering Taps Sherwood Butler as Vice President
prnewswire.com
MRNA
BIIB
VRTX
NVS
SNY
PFE
CRSP
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy
globenewswire.com
CYTK
SNY
Press release: Availability of the Q4 2025 Aide memoire
globenewswire.com
SNY
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
globenewswire.com
SNY
Reichman Jorgensen Lehman & Feldberg Welcomes Top IP Trial and Appellate Lawyer Nathan Mammen as Partner
prnewswire.com
AMGN
SNY
Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic
globenewswire.com
SNY
ドレン・バイオ、次世代B細胞枯渇療法の開発に向けてサノフィとの戦略的協業を拡大
businesswire.com
SNY
ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy
prnewswire.com
SNY